Cellosaurus logo
expasy logo

Cellosaurus NK-TY2 (CVCL_F0XV)

[Text][XML][JSON]
Cell line name NK-TY2
Accession CVCL_F0XV
Resource Identification Initiative To cite this cell line use: NK-TY2 (RRID:CVCL_F0XV)
Comments Group: Patented cell line.
Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-7865.
Population: Japanese.
Characteristics: IL2 dependent (Patent=US7781210).
Doubling time: 72 hours (Patent=US7781210).
Donor information: Although the patient was Epstein-Barr virus positive, the cell line is not.
Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
Cell type: NK T-cell; CL=CL_0000814.
Disease Nasal type extranodal NK/T-cell lymphoma (NCIt: C4684)
Extranodal nasal NK/T cell lymphoma (ORDO: Orphanet_86879)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 45Y
Category Cancer cell line
Publications

Patent=US7781210
Junjiro Tsuchiyama, Tadashi Yoshino, Mine Harada;
Epstein-Barr virus-negative NK cell line.
Patent number US7781210, 24-Aug-2010

Entry history
Entry creation27-Nov-2025
Last entry update27-Nov-2025
Version number1